GlaxoSmithKline (GSK) Fined $3 Billion

“Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. “Today’s multibillion dollar settlement is unprecedented in both size and scope,“ Deputy Attorney General James M. Cole said in a press conference. The investigation unearthed at least a decade’s worth of physician kickbacks, fraudulent marketing, and various other kinds
Back to Top